(Q28211178)

0 references

Narendra Chirmule

0 references

Frank S Lee

0 references

Nelson A Wivel

0 references

Adam Bagg

0 references

Guang-ping Gao

0 references

Mark L Batshaw

0 references

language of work or name

English

0 references

publication date

2003

1 reference

Molecular Genetics and Metabolism

PubMed

published in

0 references

volume

0 references

issue

1-2

0 references

page(s)

148-58

0 references

cites work

Liver transplantation for the treatment of urea cycle disorders

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.016

Efficient adenoviral-mediated ornithine transcarbamylase expression in deficient mouse and human hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.016

Evaluation of the transfer and expression in mice of an enzyme-encoding gene using a human adenovirus vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.016

Patient selection may affect gene therapy success. Dominant negative effects observed for ornithine transcarbamylase in mouse and human hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.016

Prolonged metabolic correction in adult ornithine transcarbamylase-deficient mice with adenoviral vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.016

Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.016

Adenovirus-mediated in vivo gene transfer rapidly protects ornithine transcarbamylase-deficient mice from an ammonium challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.016

Gene transfer into the liver of nonhuman primates with E1-deleted recombinant adenoviral vectors: safety of readministration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.016

Modulation of the inflammatory properties and hepatotoxicity of recombinant adenovirus vectors by the viral E4 gene products.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.016

Persistent transgene expression in mouse liver following in vivo gene transfer with a delta E1/delta E4 adenovirus vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.016

Evaluating the potential of germ line transmission after intravenous administration of recombinant adenovirus in the C3H mouse.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.016

Selective gene transfer into the liver of non-human primates with E1-deleted, E2A-defective, or E1-E4 deleted recombinant adenoviruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.016

Intra-arterial administration of a replication-selective adenovirus (dl1520) in patients with colorectal carcinoma metastatic to the liver: a phase I trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.016

A pilot study of in vivo liver-directed gene transfer with an adenoviral vector in partial ornithine transcarbamylase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.016

Mosaicism for an intragenic deletion in a boy with mild ornithine transcarbamylase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.016

Treatment of episodic hyperammonemia in children with inborn errors of urea synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.016

The acute respiratory distress syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.016

Postinjury multiple organ failure: a bimodal phenomenon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.016

Early predictors of postinjury multiple organ failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.016

Update on the mechanisms of immune suppression of injury and immune modulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.016

Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.016

Infections and the inflammatory response in acute respiratory distress syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.016

Activation of coagulation after administration of tumor necrosis factor to normal subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.016

The cytokine-mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.016

Inhibition of tumor necrosis factor alpha decreases inflammation and prolongs adenovirus gene expression in lung and liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.016

Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.016

Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.016

The pathogenesis of sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.016

Release of anti-inflammatory mediators after major torso trauma correlates with the development of postinjury multiple organ failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.016

Pattern of soluble TNF receptors I and II in sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.016

MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.016

Persistence of Replication-Deficient Adenovirus-Mediated Gene Transfer in Lungs of Immune-Deficient (nu/nu) Mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.016

Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.016

Adenovirus-mediated transfer of human factor IX gene in immunodeficient and normal mice: evidence for prolonged stability and activity of the transgene in liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.016

Immune Responses to Reporter Proteins and High Viral Dose Limit Duration of Expression with Adenoviral Vectors: Comparison of E2a Wild Type and E2a Deleted Vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.016

Sequestration of adenoviral vector by Kupffer cells leads to a nonlinear dose response of transduction in liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.016

Long-term gene delivery into the livers of immunocompetent mice with E1/E4-defective adenoviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.016

inferred from DOI database lookup

7 January 2021

based on heuristic

Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.016